OncoVerse Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 2

OncoVerse General Information

Description

Developer of digital health care platform designed to enable a patient's care team to collaborate in real-time, allowing clinicians across all disciplines to work together to determine the most effective treatment plan for cancer patients. The company's digital health oncology care platform has the potential to transform cancer care delivery by establishing a common platform for all cancer patients to access the best medical expertise, while at the same time providing physicians with an opportunity to present their oncology cases for evidence-based peer collaboration, review, treatment recommendations and second opinions that are available 24/7 from any computer or other web-enabled device enabling cancer patients to get reduce administrative costs associated with high quality cancer care.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 350 Sansome Street
  • Suite 800
  • San Francisco, CA 94104
  • United States
Primary Industry
Other Healthcare Technology Systems
Other Industries
Outcome Management (Healthcare)
Acquirer
BTG
Vertical(s)
Digital Health, TMT, HealthTech
Corporate Office
  • 350 Sansome Street
  • Suite 800
  • San Francisco, CA 94104
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

OncoVerse Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore OncoVerse‘s full profile, request access.

Request a free trial

OncoVerse Executive Team (1)

Name Title Board Seat
Steven Curd Chief Executive Officer
To view OncoVerse’s complete executive team members history, request access »

OncoVerse Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore OncoVerse‘s full profile, request access.

Request a free trial

OncoVerse FAQs

  • When was OncoVerse founded?

    OncoVerse was founded in 2016.

  • Who is the CEO of OncoVerse?

    Steven Curd is the CEO of OncoVerse.

  • Where is OncoVerse headquartered?

    OncoVerse is headquartered in San Francisco, CA.

  • What industry is OncoVerse in?

    OncoVerse’s primary industry is Other Healthcare Technology Systems.

  • Is OncoVerse a private or public company?

    OncoVerse is a Private company.

  • What is OncoVerse’s current revenue?

    The current revenue for OncoVerse is .

  • Who are OncoVerse’s investors?

    Wanda Health has invested in OncoVerse.

  • When was OncoVerse acquired?

    OncoVerse was acquired on 24-Apr-2017.

  • Who acquired OncoVerse?

    OncoVerse was acquired by BTG.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »